FDA Inspection
Unilever Manufacturing (US), Inc.Unilever Manufacturing (US), Inc. – FDA Inspection, Mar 10, 2020
Record Details
This FDA Inspection record concerns Unilever Manufacturing (US), Inc., with an inspection on March 10, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- March 10, 2020
- Product Type
- Drugs
View Company Profile
ID · ed7479d8-73a2-4317-a645-7ca906399315
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1120502
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.192Written record of investigation incomplete
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Unilever Manufacturing (US), Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 15, 2025 | VAI | Dallas District Office | Drug Quality Assurance |
| July 10, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Unilever Manufacturing (US), Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.